VC
Value Add VC
Pulse
🏢
Companies
💼
Investors
📝
Research
🛠️
Data & Tools
🧰
Tools
🤝
Partner
Intelligence
/
Investors
/
Merck Ventures
Merck Ventures
Venture capital firm
Follow
We track Merck Ventures but have little verified detail yet.
Latest Pulse
Pulse coverage →
Jul 7, 2026
Cyllene Therapeutics Raises €33M for Gene Therapy
Cyllene Therapeutics, formerly EG 427, raised €33 million co-led by Merck Ventures to advance its HSV-1 gene-therapy platform toward treating neurogenic bladder conditions.
→
Suggest a correction